Vimarsana
Biggest News Aggregation in the World

Morten Schmidt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morten Schmidt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morten Schmidt Today - Breaking & Trending Today

NSAIDs With Hormonal Birth Control Tied to Blood Clot Risk - Vimarsana News

NSAIDs With Hormonal Birth Control Tied to Blood Clot Risk

Women taking birth control pills with estrogen more likely to have adverse events, study finds

Hormonal Birth Control, NSAID Use Together Linked to VTE - Vimarsana News

Hormonal Birth Control, NSAID Use Together Linked to VTE

Though the absolute risk is low, clinicians can advise their female patients on ways to avoid what might be additive risks.

Source: tctmd.com
Use of common painkillers alongside hormonal contraception linked to heightened risk of blood clots - Vimarsana News

Use of common painkillers alongside hormonal contraception linked to heightened risk of blood clots

Women who use non-steroidal anti-inflammatory painkillers alongside hormonal contraception appear to be at a small increased risk of blood clots known as venous thromboembolism (VTE), finds a large Danish study published by The BMJ today

'Higher blood clot risk' if ibuprofen and hormonal contraception used together - Vimarsana News

'Higher blood clot risk' if ibuprofen and hormonal contraception used together

Research suggests that women should consider alternatives to avoid 'potentially fatal event'

NSAIDs, hormonal contraception, and venous thromboembolism - Vimarsana News

NSAIDs, hormonal contraception, and venous thromboembolism

A harmful drug interaction that deserves more attention Venous thromboembolism is a multifactorial disease, involving interactions between inherited and acquired risk factors such as immobilisation, active cancer, trauma or fracture, recent surgery, and—in young women—pregnancy and hormonal contraception.1 The magnitude of the risk from combined hormonal contraception depends on the dose of oestrogen and type of progestin.2 Although oestrogen causes hypercoagulability by promoting gene transcription of multiple coagulation factors, the role of progestin is less clear.3 In a linked paper, M...

Source: bmj.com
Related Topics:
Morten Schmidt